Well let's hope for everyone's sake he can provide an update which isn't selective in its wording and provides an insightful outlook so we can all try and understand where this company is at. The stuff I like is the honesty ie when he announced teva didn't want to extend the agreement into the optional territories. It shows conviction to the cause. If something is running late or if something is dead just tell the bloody market it's dead.
Provide an update on the following and just be honest and to the best of your knowledge.
002 / zolpi Euro - - expected deal timelines against guidance now that we are QTR 3 FY19
005 / anagrelide - any kind of update would do here, seems like both have fallen off the cliff
Co development / CBD deals - again any kind of update
Artimist- -update on TGA -update on WHO meeting
Strangely enough it's the stuff that he announces that isn't good news that makes me think we are progressing somewhere and it's the stuff he selectively doesn't announce that makes me think .005 is exactly where this company's at.
SUD Price at posting:
0.6¢ Sentiment: Buy Disclosure: Held